A spokesperson from Alan Meds who recognized herself only as Olivia sent an electronic mail noting that “licensed physicians” evaluate each scenario, “adhering to FDA guidelines for GLP-1 prescriptions.” She noted which they assessed “BMI, comorbidities, current remedies, together with other lifestyle aspects” to determine eligibility.